Compass Pathways Plc - ADR Stock
$4.33
0.92%
Nasdaq,
Jul 25, 10:14 pm CET
Compass Pathways Plc - ADR Stock price
$4.33
+1.57
56.88%
1M
+0.72
19.94%
6M
+0.55
14.55%
YTD
-3.13
41.96%
1Y
-10.58
70.96%
3Y
-12.67
74.53%
5Y
-12.67
74.53%
10Y
-12.67
74.53%
20Y
Nasdaq,
Closing price Fri, Jul 25 2025
-0.04
0.92%
Powered by
ISIN
US20451W1018
Symbol
CMPS
Index
Industry
Key metrics
Basic
Market capitalization
$405.8m
Enterprise Value
$176.2m
Net debt
positive
Cash
$260.1m
Shares outstanding
92.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
2.1
Financial Health
Equity Ratio
72.4%
Return on Equity
-100.3%
ROCE
-65.5%
ROIC
-
Debt/Equity
0.2
Show more
Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
Compass Pathways Plc - ADR Stock Analysis
Unlock Scores for Free
Analyst Opinions
16 Analysts have issued a Compass Pathways Plc - ADR forecast:
Analyst Opinions
16 Analysts have issued a Compass Pathways Plc - ADR forecast:
Buy
88%
Hold
13%
Financial data from Compass Pathways Plc - ADR
| Mar '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -189 -189 |
42%
42%
|
EBIT (Operating Income) EBIT | -189 -189 |
42%
42%
|
| Net Profit | -138 -138 |
6%
6%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Compass Pathways Plc - ADR Stock News
Neutral
Business Wire
●
6 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter ended June 30, 2025, and provide an update on recent developments, on July 31, 2025. Compass management will host a...
Positive
The Motley Fool
●
8 days ago
Investors seeking stocks that can put up dramatic gains in a short amount of time can find what they're looking for in the biotechnology industry. Investment bank analysts on Wall Street have tagged a pair of pre-revenue businesses with price targets that are miles above their current stock prices.
Neutral
Business Wire
●
17 days ago
NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat with Patrick Trucchio, Managing Director Equity Research at HC Wainwright at 8:00 am ET on July 14th, 2025. A live audio webcast of th...
Company Profile
| Head office | United Kingdom |
| CEO | Kabir Nath |
| Employees | 166 |
| Founded | 2016 |
| Website | compasspathways.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
